Insights into roles of METTL14 in tumors.

Abstract

N6-Methyladenosine (m6A) is considered the most common and endogenous modification of eukaryotic RNAs. Highly conserved in many species, m6A regulates RNA metabolism, cell differentiation, cell circadian rhythm, and cell cycle; it also responds to endogenous and exogenous stimuli and is associated with the development of tumors. The m6A methyltransferase complex (MTC) regulates the m6A modification of transcripts and involves two components, methyltransferase-like enzyme 3 (METTL3) and methyltransferase-like enzyme 14 (METTL14), and other auxiliary regulatory distinct components. Though with no catalytic effect, METTL14 serves as an RNA-binding scaffold in MTC, promotes RNA substrate recognition, activates, and escalates the catalytic capability of METTL3, thus accounting for a pivotal member of the complex. It was reported that METTL14 regulates tumor proliferation, metastasis, and self-renewal, and plays a part in tumorigenesis, tumor progression, and other processes. The present work is a review of the role of METTL14 both as a tumor suppressor and a tumor promoter in the oncogenesis and progression of various tumors, as well as the potential molecular mechanisms.

• Authors: Xin Liu, Yuping Du, Zhenghao Huang, Honglei Qin, Jingwen Chen, Yang Zhao
• Journal: Cell proliferation (Cell Prolif) Vol. 55 Issue 1 Pg. e13168 (Jan 2022) ISSN: 1365-2184 [Electronic] England
• PMID: 34904301 (Publication Type: Journal Article, Review)
• Copyright: © 2021 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.

Chemical References

• RNA
• N-methyladenosine
• Methyltransferases
• Adenosine

Topics

• Adenosine (analogs & derivatives, metabolism)
• Animals
• Genes, Tumor Suppressor
• Humans
• Methyltransferases (chemistry, genetics, metabolism)
• Neoplasms (enzymology, genetics)
• Oncogenes
• RNA (metabolism)